|
Market Closed -
Nasdaq
01:00:00 14/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.090 USD | +9.36% |
|
+2.25% | -25.64% |
| 10-28 | Adial Pharmaceuticals, Inc.(NasdaqCM:ADIL) dropped from NASDAQ Composite Index | CI |
| 10-26 | Adial Pharmaceuticals, Inc. Announces CFO Changes | CI |
| Market Cap | 13.26M 12.02M 11.11M 10.03M 18.9M 1.25B 19.56M 134M 52.94M 668M 49.76M 48.71M 2.12B | P/E 2026 * |
-3.34x | P/E 2027 * | -8.28x |
|---|---|---|---|---|---|
| Enterprise Value | 13.26M 12.02M 11.11M 10.03M 18.9M 1.25B 19.56M 134M 52.94M 668M 49.76M 48.71M 2.12B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ADIL PHARPAR
| 08/03/23 | Wall Street kleurt rood door Powell | |
| 07/03/23 | Havikige Powell duwt Wall Street in het rood | |
| 07/03/23 | Wall Street wacht op Powell |
| 1 day | +9.36% | ||
| Current month | -19.01% | ||
| 1 month | +30.25% | ||
| 3 months | -18.04% | ||
| 6 months | +196.38% | ||
| Current year | -25.64% |
| 1 month | 3.07 |  | 5.15 |
| Current year | 1.31 | | 7.2 |
| 1 year | 1.31 | | 8.24 |
| 3 years | 1.31 | | 104.25 |
| 5 years | 1.31 | | 2,200 |
| 10 years | 1.31 | | 5,900 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/09/26 | Free | Director | 25,666 | 0.9774% | ||
| 07/04/26 | Free | Chief Financial Officer | 17,325 | 1.2133% | ||
| 07/04/26 | Free | Chairman | 9,185 | 0.6432% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -65.46M -59.32M -54.87M -49.5M -93.29M -6.17B -96.58M -659M -261M -3.3B -246M -240M -10.47B | -21.14M -19.15M -17.72M -15.99M -30.12M -1.99B -31.19M -213M -84.39M -1.06B -79.32M -77.64M -3.38B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $4.090 | +9.36% | 10,966 |
| 12/11/26 | $3.740 | +6.55% | 50,813 |
| 11/11/26 | $3.510 | -6.65% | 11,064 |
| 10/11/26 | $3.760 | +0.27% | 83,518 |
| 09/11/26 | $3.750 | -6.25% | 31,682 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ADIL Stock
Select your edition
All financial news and data tailored to specific country editions
